Vertex Pharmaceuticals: Trikafta And Alyftrek Cement Market Leadership

Vertex's revenue was $2.96 billion in the second quarter of 2025, beating the consensus forecast by $58 million. Click here ...

Vertex Pharmaceuticals: I'm Downgrading To Hold On Drug Pricing, Pipeline Concerns

Vertex faces pressure from potential U.S. drug pricing reforms and tariffs. Click here to find out why VRTX stock is a Hold.
Endovascular Today

Jupiter Endovascular’s Vertex Catheter Receives FDA Clearance

Jupiter Endovascular, Inc. announced that its Vertex catheter has received FDA 510(k) clearance for the insertion of endovasc ...
cryptopolitan

Filecoin price prediction 2025-2031: What’s the future for FIL?

Filecoin is a decentralized storage network designed to securely and efficiently store humanity’s most important information. Launched by Protocol Labs in October 2020, it utilizes blockchain ...